BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20732906)

  • 21. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
    Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
    Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of GEMIN4 gene polymorphisms with the risk of colorectal cancer in the Polish population.
    Cieślak A; Galita G; Mik M; Dziki Ł; Dziki A; Sokołowski I; Popławski T; Majsterek I
    Pol Przegl Chir; 2021 Nov; 93(0):40-45. PubMed ID: 35384865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome.
    Bai Y; Guo Z; Xu J; Liu S; Zhang J; Cui L; Zhang H; Zhang S
    Mitochondrial DNA; 2015 Apr; 26(2):224-6. PubMed ID: 24021012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.
    Schutz FA; Pomerantz MM; Gray KP; Atkins MB; Rosenberg JE; Hirsch MS; McDermott DF; Lampron ME; Lee GS; Signoretti S; Kantoff PW; Freedman ML; Choueiri TK
    Lancet Oncol; 2013 Jan; 14(1):81-7. PubMed ID: 23219378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
    Ye Y; Wang KK; Gu J; Yang H; Lin J; Ajani JA; Wu X
    Cancer Prev Res (Phila); 2008 Nov; 1(6):460-9. PubMed ID: 19138993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.
    van Bemmel DM; Boffetta P; Liao LM; Berndt SI; Menashe I; Yeager M; Chanock S; Karami S; Zaridze D; Matteev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Slamova A; Rothman N; Han SS; Rosenberg PS; Brennan P; Chow WH; Moore LE
    PLoS One; 2011; 6(7):e20432. PubMed ID: 21799727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
    Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
    Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.
    Karami S; Brennan P; Rosenberg PS; Navratilova M; Mates D; Zaridze D; Janout V; Kollarova H; Bencko V; Matveev V; Szeszenia-Dabrowska N; Holcatova I; Yeager M; Chanock S; Menashe I; Rothman N; Chow WH; Boffetta P; Moore LE
    PLoS One; 2009 Sep; 4(9):e7013. PubMed ID: 19753122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Black carbon exposures, blood pressure, and interactions with single nucleotide polymorphisms in MicroRNA processing genes.
    Wilker EH; Baccarelli A; Suh H; Vokonas P; Wright RO; Schwartz J
    Environ Health Perspect; 2010 Jul; 118(7):943-8. PubMed ID: 20211803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
    Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
    Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.
    Teixeira AL; Dias F; Ferreira M; Gomes M; Santos JI; Lobo F; Maurício J; Machado JC; Medeiros R
    PLoS One; 2014; 10(4):e0103258. PubMed ID: 25909813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
    Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
    PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.
    Chen X; Sturgis EM; Wang C; Cao X; Li Y; Wei Q; Li G
    Oncotarget; 2016 Jun; 7(23):35015-25. PubMed ID: 27145460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G
    Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Slaby O; Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R
    Genes Chromosomes Cancer; 2012 Jul; 51(7):707-16. PubMed ID: 22492545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt antagonist gene polymorphisms and renal cancer.
    Hirata H; Hinoda Y; Nakajima K; Kikuno N; Yamamura S; Kawakami K; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
    Cancer; 2009 Oct; 115(19):4488-503. PubMed ID: 19562778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression.
    Liu Y; Han X; Yu Y; Ding Y; Ni C; Liu W; Hou X; Li Z; Hou J; Shen D; Yin J; Zhang H; Thompson TC; Tan X; Cao G
    Sci Rep; 2016 May; 6():26689. PubMed ID: 27225192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.